yfdN Antibody is a polyclonal antibody developed against the uncharacterized protein yfdN from Escherichia coli. According to available information, the antibody specifically reacts with Escherichia coli (strain K12) and has been validated for techniques including ELISA and Western blotting . The antibody is typically raised in rabbits using recombinant Escherichia coli uncharacterized protein yfdN as the immunogen, similar to other bacterial antibodies described in the literature . The development process typically includes affinity purification to ensure high specificity for the target protein.
The antibody's specificity is crucial for researchers studying E. coli proteins, particularly in experiments involving protein detection and characterization. Unlike commercial antibodies targeting well-characterized proteins, those targeting uncharacterized proteins like yfdN require careful validation in each experimental system.
Recombinant Escherichia coli uncharacterized protein yfdN can be produced in multiple expression systems including:
Yeast expression systems
E. coli-based expression systems
Baculovirus expression systems
The choice of expression system significantly impacts protein folding, post-translational modifications, and ultimately the epitopes recognized by the antibody. For bacterial proteins like yfdN, E. coli expression systems often provide native-like protein conformation, though yeast-based systems may offer advantages for certain applications requiring eukaryotic post-translational processing machinery.
Based on available information, yfdN Antibody has been validated for:
The technical parameters for experimental design should consider:
| Application | Recommended Dilution | Incubation Time | Detection Method |
|---|---|---|---|
| ELISA | 1:500 - 1:2000* | 1-2 hours at RT | HRP/AP conjugates |
| Western Blot | 1:200 - 1:1000* | Overnight at 4°C | ECL/fluorescence |
*Note: Optimal dilutions should be determined experimentally for each new lot of antibody, similar to protocols used for other bacterial protein antibodies .
The antibody's performance in these applications makes it suitable for detecting yfdN protein expression patterns, studying protein-protein interactions, and evaluating protein localization in bacterial systems.
Proper experimental controls are essential for interpreting results with yfdN Antibody:
Positive control: Recombinant yfdN protein (200μg typically provided with antibody kits) should be used as a positive control to confirm antibody specificity .
Negative control: Pre-immune serum (typically 1ml provided with antibody kits) serves as an appropriate negative control to identify non-specific binding .
Blocking validation: Compare results with and without blocking agents to ensure signal specificity.
Knock-out/knock-down controls: When possible, use E. coli strains with yfdN gene deletion or suppression.
Cross-reactivity controls: Test the antibody against related bacterial species to determine specificity across taxonomic boundaries.
Implementing these controls helps distinguish between specific signals and background noise, particularly important when working with antibodies targeting uncharacterized proteins.
For optimal Western Blot performance with yfdN Antibody, researchers should consider the following protocol parameters:
Sample preparation:
Bacterial cultures should be harvested during logarithmic growth phase
Lyse cells in buffer containing 50mM Tris-HCl (pH 8.0), 150mM NaCl, 1% NP-40, with protease inhibitors
Sonicate samples (6 × 10s pulses) to ensure complete lysis
Gel electrophoresis conditions:
12-15% SDS-PAGE gels typically provide optimal resolution for bacterial proteins in the expected molecular weight range
Load 20-30μg of total protein per lane
Transfer parameters:
Use PVDF membrane (0.45μm pore size) for optimal protein binding
Transfer at 100V for 60 minutes in cold transfer buffer with 20% methanol
Blocking and antibody incubation:
Block with 5% non-fat dry milk in TBST for 1 hour at room temperature
Incubate with primary antibody (1:500 dilution) overnight at 4°C
Wash 3 × 10 minutes with TBST
Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature
Detection:
Use enhanced chemiluminescence (ECL) detection
Expose membrane for 30 seconds initially, then adjust exposure time as needed
These conditions should be optimized based on specific experimental requirements, similar to protocols used for other bacterial protein antibodies described in the literature .
For ELISA applications with yfdN Antibody, researchers should follow these methodological steps:
Plate coating:
Coat 96-well plates with 100μl of recombinant yfdN protein (2-5μg/ml) or bacterial lysate in coating buffer (50mM carbonate-bicarbonate, pH 9.6)
Incubate overnight at 4°C
Blocking:
Block with 300μl of 3% BSA in PBS for 2 hours at room temperature
Sample preparation:
Prepare serial dilutions of test samples in sample buffer (PBS with 1% BSA)
Add 100μl per well and incubate for 2 hours at room temperature
Antibody incubation:
Add yfdN Antibody diluted 1:1000 in antibody diluent (PBS with 1% BSA)
Incubate for 1 hour at room temperature
Wash 4 × 5 minutes with PBST (PBS with 0.05% Tween-20)
Detection:
Add HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature
Wash 4 × 5 minutes with PBST
Develop with TMB substrate for 15-30 minutes
Stop reaction with 2N H₂SO₄ and read absorbance at 450nm
This protocol should be optimized based on specific experimental requirements. ELISA applications enable quantitative analysis of yfdN protein levels and can be adapted for competitive or sandwich ELISA formats to address specific research questions .
When encountering issues with yfdN Antibody performance, researchers should consider the following troubleshooting approaches:
For non-specific binding:
Increase blocking agent concentration to 5% BSA or 5% non-fat dry milk
Add 0.1-0.5% Triton X-100 to washing buffer to reduce hydrophobic interactions
Pre-absorb antibody with E. coli lysate lacking yfdN expression
Decrease primary antibody concentration
Increase washing duration and frequency (5 × 10 minutes)
For weak signal detection:
Increase protein loading (up to 50μg per lane for Western blot)
Increase antibody concentration in stepwise manner
Extend primary antibody incubation time to 48 hours at 4°C
Use signal enhancement systems like biotin-streptavidin amplification
Consider more sensitive detection methods (e.g., chemiluminescent substrates with higher sensitivity)
For inconsistent results:
Test multiple antibody lots if available
Verify protein expression conditions and timing
Check for protein degradation by adding additional protease inhibitors
Optimize lysis conditions to ensure complete protein extraction
These troubleshooting strategies are based on general principles for optimizing antibody-based detection methods and should be adapted to specific experimental contexts .
Sample preparation significantly impacts the performance of yfdN Antibody in experimental applications:
Protein denaturation effects:
For Western blot, complete denaturation with SDS and β-mercaptoethanol ensures epitope exposure
For immunoprecipitation, milder detergents (0.5% NP-40) help maintain native conformation and protein-protein interactions
Fixation considerations:
Paraformaldehyde fixation (4%) for 15 minutes preserves protein structure while maintaining epitope accessibility
Methanol fixation may improve accessibility of some epitopes but can disrupt certain conformational epitopes
Extraction buffer composition:
Ionic strength affects antibody-antigen interaction; optimal results typically occur at 150-300mM NaCl
pH optimization between 7.0-8.0 is recommended for maximum antibody binding
Proteolytic degradation prevention:
Include protease inhibitor cocktail in all extraction buffers
Maintain samples at 4°C throughout processing
Avoid freeze-thaw cycles that can lead to protein degradation
Protein aggregation considerations:
Include mild detergents (0.1% Triton X-100) to prevent hydrophobic aggregation
Sonicate samples briefly to disrupt protein aggregates that may mask epitopes
Optimizing these parameters improves consistency and sensitivity when using yfdN Antibody for protein detection and characterization .
For investigating protein-protein interactions involving yfdN, researchers can employ the following methodologies:
Co-immunoprecipitation (Co-IP):
Lyse bacteria in non-denaturing buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40)
Pre-clear lysate with Protein A/G beads for 1 hour at 4°C
Incubate lysate with yfdN Antibody (5μg) overnight at 4°C
Add Protein A/G beads and incubate for 2 hours at 4°C
Wash 5× with washing buffer
Elute and analyze interacting proteins by mass spectrometry or Western blot
Proximity-dependent biotin identification (BioID):
Generate fusion constructs of yfdN with a promiscuous biotin ligase (BirA*)
Express in bacteria and supply biotin to culture medium
Purify biotinylated proteins using streptavidin beads
Identify interaction partners by mass spectrometry
Verify interactions using yfdN Antibody in confirmatory Western blots
Pull-down assays with recombinant proteins:
Express recombinant yfdN with affinity tags (His, GST)
Immobilize on appropriate affinity resin
Incubate with bacterial lysate or recombinant candidate interactors
Wash extensively and elute bound proteins
Analyze using yfdN Antibody to confirm successful pull-down
These approaches provide complementary data on protein-protein interactions and can reveal the functional role of yfdN in bacterial cellular processes .
Understanding the specific epitope recognized by yfdN Antibody is crucial for interpretation of experimental results. Researchers can employ these methodological approaches:
Epitope mapping by peptide array:
Synthesize overlapping peptides (15-20 amino acids) spanning the entire yfdN protein sequence
Spot peptides onto membranes in an array format
Probe with yfdN Antibody using standard immunoblotting procedures
Identify reactive peptides to define the linear epitope region
Alanine scanning mutagenesis:
Generate variants of yfdN with systematic alanine substitutions
Express and purify mutant proteins
Test antibody binding to each mutant using ELISA or Western blot
Identify critical residues for antibody recognition
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Perform HDX-MS on yfdN protein alone and in complex with the antibody
Compare deuterium incorporation patterns
Regions protected from exchange when antibody is bound indicate the epitope location
X-ray crystallography or cryo-EM of antibody-antigen complex:
Purify the antibody-antigen complex
Determine the three-dimensional structure
Precisely identify contact residues at the binding interface
These approaches provide increasing levels of resolution for epitope characterization, from identification of the general region to atomic-level detail of the binding interface .
When selecting between polyclonal and monoclonal antibodies for yfdN research, consider these comparative factors:
| Characteristic | Polyclonal yfdN Antibody | Monoclonal yfdN Antibody |
|---|---|---|
| Epitope recognition | Multiple epitopes across yfdN protein | Single epitope with higher specificity |
| Sensitivity | Generally higher sensitivity due to multiple binding sites | May have lower sensitivity but higher specificity |
| Batch-to-batch variability | Moderate to high variability | Low variability with consistent performance |
| Production complexity | Simpler production process | Complex hybridoma development required |
| Applications | Excellent for detection in multiple assays | Superior for epitope-specific applications |
| Cross-reactivity | Potential for higher cross-reactivity | Minimal cross-reactivity with closely related proteins |
| Cost considerations | Generally more cost-effective | Higher development and production costs |
Polyclonal antibodies like the standard yfdN Antibody offer advantages for initial characterization studies and applications requiring detection of denatured proteins. Monoclonal antibodies would provide benefits for applications requiring absolute specificity or where batch consistency is critical .
Developing multiplex assays incorporating yfdN Antibody requires careful methodological considerations:
Antibody compatibility assessment:
Test for cross-reactivity between primary and secondary antibodies
Ensure no epitope masking occurs when multiple antibodies are used
Validate specificity of each antibody individually before multiplexing
Fluorophore selection for immunofluorescence:
Choose fluorophores with minimal spectral overlap
Recommended combinations:
yfdN Antibody: Cy3 (550/570nm)
Antibody 2: FITC (495/519nm)
Antibody 3: Cy5 (650/670nm)
Sequential staining protocol:
Fix samples in 4% paraformaldehyde for 15 minutes
Block with 5% BSA in PBS for 1 hour
Apply first primary antibody (1:500) for 2 hours
Wash 3 × 10 minutes
Apply first secondary antibody (1:1000) for 1 hour
Wash 3 × 10 minutes
Repeat for subsequent antibodies with appropriate controls
Multiplex Western blot approaches:
Use antibodies from different host species
Apply fluorescently-labeled secondary antibodies with distinct spectra
Image using multi-channel fluorescence detection
Alternative: strip and reprobe membrane (less reliable but more accessible)
These strategies allow simultaneous detection of multiple targets including yfdN protein alongside other bacterial or host proteins of interest .
For investigating the subcellular localization of yfdN protein, researchers should consider these methodological approaches:
Immunofluorescence microscopy:
Fix bacterial cells with 4% paraformaldehyde for 15 minutes
Permeabilize with 0.1% Triton X-100 for 5 minutes
Block with 3% BSA for 30 minutes
Incubate with yfdN Antibody (1:200) for 2 hours at room temperature
Wash 3 × 5 minutes with PBS
Incubate with fluorescently-labeled secondary antibody (1:500) for 1 hour
Counterstain with DAPI to visualize DNA
Image using confocal or super-resolution microscopy
Immunoelectron microscopy:
Fix bacteria with 4% paraformaldehyde/0.1% glutaraldehyde
Embed in LR White resin
Prepare ultrathin sections on nickel grids
Block with 1% BSA in PBS
Incubate with yfdN Antibody (1:50) overnight at 4°C
Apply gold-conjugated secondary antibody (10nm particles)
Counterstain with uranyl acetate and lead citrate
Examine using transmission electron microscopy
Subcellular fractionation with immunoblotting:
Separate bacterial components (membrane, cytoplasm, periplasm)
Prepare protein extracts from each fraction
Perform Western blot analysis using yfdN Antibody
Use marker proteins for each compartment as controls
These approaches provide complementary information about yfdN localization patterns under different growth conditions or experimental treatments .
When investigating bacterial stress responses using yfdN Antibody, researchers should implement these methodological considerations:
Experimental design for stress conditions:
Establish appropriate stress parameters (temperature, pH, osmotic pressure)
Determine optimal timepoints for protein expression analysis
Include appropriate controls for each stress condition
Sample collection protocol:
Harvest equal numbers of bacteria from each condition
Process samples identically to avoid artificial differences
Preserve samples quickly to prevent stress-induced changes during processing
Quantitative analysis approaches:
Use quantitative Western blot with internal loading controls
Employ image analysis software for densitometry
Normalize yfdN protein levels to constitutively expressed proteins
Time-course considerations:
Collect samples at multiple timepoints (0, 15, 30, 60, 120 minutes)
Process simultaneously to minimize technical variation
Consider both acute and adaptive responses
Complementary methods:
Pair protein level analysis with transcriptional studies (qRT-PCR)
Consider proteomic approaches for global protein changes
Use genetic approaches (knockouts, overexpression) to validate findings
This systematic approach allows researchers to determine whether yfdN protein expression changes in response to specific environmental challenges, potentially revealing its functional role in bacterial adaptation .
To characterize potential post-translational modifications (PTMs) of yfdN protein, researchers can implement these methodological approaches:
Modification-specific detection:
Use yfdN Antibody for initial immunoprecipitation
Probe with antibodies specific for PTMs (phosphorylation, acetylation, etc.)
Compare migration patterns on SDS-PAGE before/after treatment with modification-removing enzymes
Mass spectrometry workflow:
Immunoprecipitate yfdN protein using the antibody
Perform in-gel digestion with trypsin
Analyze peptides by LC-MS/MS
Search for mass shifts indicative of modifications
Confirm with targeted MS/MS of modified peptides
2D gel electrophoresis analysis:
Separate proteins by isoelectric point and molecular weight
Transfer to membrane and probe with yfdN Antibody
Identify charge variants indicative of modifications
Excise spots for MS identification of modifications
Phosphorylation-specific analysis:
Treat bacterial cultures with phosphatase inhibitors
Immunoprecipitate with yfdN Antibody
Perform Western blot with phospho-specific antibodies
Use Phos-tag™ SDS-PAGE to enhance separation of phosphorylated forms
These approaches enable comprehensive characterization of PTMs, providing insights into regulatory mechanisms affecting yfdN protein function .
For investigating yfdN's potential role in bacterial pathogenesis, researchers can implement these experimental approaches:
Infection time-course analysis:
Infect host cells or animal models with E. coli
Collect samples at defined timepoints post-infection
Process for protein extraction under denaturing conditions
Analyze yfdN protein levels by Western blot
Correlate with bacterial burden and infection progression
Immunohistochemistry of infected tissues:
Process infected tissue sections using standard fixation
Perform antigen retrieval if necessary
Block with serum-based blocking buffer
Apply yfdN Antibody (1:100) overnight at 4°C
Develop with DAB or fluorescent detection systems
Counterstain to visualize tissue architecture
Co-localization studies during infection:
Perform dual immunofluorescence with:
yfdN Antibody
Antibodies against host defense proteins
Analyze using confocal microscopy
Quantify co-localization using appropriate software
Functional blocking experiments:
Pre-treat bacteria with yfdN Antibody before infection
Assess changes in bacterial adherence, invasion, or survival
Compare with isotype control antibody treatment
Quantify by CFU counts or fluorescence microscopy
These methods can help elucidate whether yfdN protein expression changes during infection and if it plays a role in bacterial-host interactions, potentially identifying it as a virulence factor or stress response protein .
Several cutting-edge technologies hold promise for expanding yfdN Antibody applications:
Single-cell proteomics integration:
Combine yfdN Antibody with mass cytometry (CyTOF)
Implement microfluidic single-cell Western blotting
Develop proximity ligation assays for enhanced sensitivity
Apply imaging mass cytometry for tissue section analysis
Advanced microscopy applications:
Super-resolution microscopy (STORM, PALM) for nanoscale localization
Live-cell imaging with cell-permeable antibody fragments
Lattice light-sheet microscopy for dynamic protein tracking
Correlative light and electron microscopy for contextual ultrastructure
Antibody engineering approaches:
Develop single-domain antibodies (nanobodies) against yfdN
Create bispecific antibodies for simultaneous target detection
Engineer antibody-enzyme fusion proteins for proximity labeling
Develop split-antibody complementation systems for interaction studies
AI-enhanced image analysis:
Machine learning algorithms for automated protein localization
Deep learning approaches for pattern recognition in complex samples
Computer vision techniques for quantitative analysis of subcellular distribution
These technological advances could significantly enhance the sensitivity, specificity, and information content obtainable from experiments using yfdN Antibody .
Cross-species comparative studies using yfdN Antibody can provide evolutionary insights:
Phylogenetic analysis workflow:
Test yfdN Antibody cross-reactivity against related bacterial species
Perform Western blot analysis on protein extracts from diverse bacteria
Correlate antibody reactivity with sequence conservation
Construct phylogenetic trees based on protein sequence and antibody recognition
Structure-function relationship studies:
Compare epitope conservation across bacterial species
Correlate antibody recognition with functional domains
Identify conserved versus variable regions using epitope mapping
Infer functional constraints based on evolutionary conservation patterns
Heterologous expression approach:
Express yfdN orthologs from different bacteria in a common host
Compare protein expression, localization, and interaction patterns
Use yfdN Antibody to assess structural conservation
Perform complementation studies to test functional conservation
Experimental evolution monitoring:
Subject bacterial cultures to selection pressure
Track changes in yfdN protein expression or modification
Use the antibody to monitor protein adaptation during evolution
Correlate with genomic changes over evolutionary time
These comparative approaches can reveal functional constraints on yfdN protein evolution and provide insights into its biological role across bacterial species .